Mymetics Corp (MYMX)

[TheHungryHippo]

Kind of reminds me of this... MACIVIVA was a big deal, MERCK might be taking this VLP system for a test drive here.

PX’Therapeutics and Mymetics joined forces several years ago to work on rgp41 protein design and development of the production and purification processes of the molecule. PX teams managed to develop an efficient, scalable and GMP-compliant process. A clinical batch was produced from a scale fermentation volume of 120 L to deliver a sufficient quantity for formulation studies and clinical trials.

Claire Untereiner, Chief Operating Officer of PX’Therapeutics, commented as follows: “We are so happy to see the progress made with this molecule and to be part of this fantastic project. MACIVIVA’s objective, the development of cold-chain independent and virosome-based vaccines, responds to a real medical need, particularly in emerging countries, and is in line with PX’Therapeutics’ mission, to support and accelerate the development of innovative medicines”.

Sylvain Fleury, Chief Scientific Officer of Mymetics SA commented: “we are pleased that PX’Therapeutics could address many technical challenges related to the GMP development of the recombinant rgp41 protein and achieve a production yield superior to our expectations. With this rgp41, Mymetics will further pursue the development of its HIV-1 candidate vaccine, which could be administered through various immunization routes, as a standalone product or combined with viral vectors in a prime-boost approach”.